The observation that ISL reduced Src phosphorylation in lung cancer cells but was ineffective to inhibit Src activity in cell-free system prompted us to hypothesize that ISL interfered with Src signaling pathway through its metabolites. The gene discussed is SRC; the disease is lung cancer.